Arcadia Biosciences (RKDA) Competitors $5.90 -0.30 (-4.84%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends RKDA vs. SEED, NCRA, SANW, IVP, CEAD, SISI, EDBL, YTEN, AAGR, and AAGRWShould you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include Origin Agritech (SEED), Nocera (NCRA), S&W Seed (SANW), Inspire Veterinary Partners (IVP), CEA Industries (CEAD), Shineco (SISI), Edible Garden (EDBL), Yield10 Bioscience (YTEN), African Agriculture (AAGR), and African Agriculture (AAGRW). These companies are all part of the "agriculture" industry. Arcadia Biosciences vs. Origin Agritech Nocera S&W Seed Inspire Veterinary Partners CEA Industries Shineco Edible Garden Yield10 Bioscience African Agriculture African Agriculture Arcadia Biosciences (NASDAQ:RKDA) and Origin Agritech (NASDAQ:SEED) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, community ranking, media sentiment and profitability. Which has more volatility and risk, RKDA or SEED? Arcadia Biosciences has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Comparatively, Origin Agritech has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Do analysts rate RKDA or SEED? Arcadia Biosciences currently has a consensus target price of $6.00, indicating a potential upside of 1.69%. Given Arcadia Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe Arcadia Biosciences is more favorable than Origin Agritech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Origin Agritech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, RKDA or SEED? Origin Agritech has higher revenue and earnings than Arcadia Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArcadia Biosciences$5.48M1.47-$13.98M-$4.28-1.38Origin Agritech$119.25M0.11$7.71MN/AN/A Does the MarketBeat Community prefer RKDA or SEED? Arcadia Biosciences received 70 more outperform votes than Origin Agritech when rated by MarketBeat users. However, 62.97% of users gave Origin Agritech an outperform vote while only 55.11% of users gave Arcadia Biosciences an outperform vote. CompanyUnderperformOutperformArcadia BiosciencesOutperform Votes28655.11% Underperform Votes23344.89% Origin AgritechOutperform Votes21662.97% Underperform Votes12737.03% Is RKDA or SEED more profitable? Origin Agritech has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -110.61%. Origin Agritech's return on equity of 0.00% beat Arcadia Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Arcadia Biosciences-110.61% -52.63% -34.57% Origin Agritech N/A N/A N/A Do insiders & institutionals have more ownership in RKDA or SEED? 17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 1.7% of Origin Agritech shares are owned by institutional investors. 1.8% of Arcadia Biosciences shares are owned by company insiders. Comparatively, 15.4% of Origin Agritech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer RKDA or SEED? In the previous week, Arcadia Biosciences had 1 more articles in the media than Origin Agritech. MarketBeat recorded 3 mentions for Arcadia Biosciences and 2 mentions for Origin Agritech. Origin Agritech's average media sentiment score of 0.63 beat Arcadia Biosciences' score of 0.48 indicating that Origin Agritech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arcadia Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Origin Agritech 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOrigin Agritech beats Arcadia Biosciences on 9 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Get Arcadia Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RKDA vs. The Competition Export to ExcelMetricArcadia BiosciencesAgricultural production IndustryMaterials SectorNASDAQ ExchangeMarket Cap$8.05M$1.64B$2.78B$9.32BDividend YieldN/A2.62%5.29%4.06%P/E Ratio-1.3816.16118.9917.54Price / Sales1.471.24761,123.77139.66Price / CashN/A52.4923.6737.95Price / Book0.521.173.464.92Net Income-$13.98M$3.37M$152.60M$225.78M7 Day Performance-3.12%3.66%-2.84%-1.56%1 Month Performance107.75%0.72%4.48%6.68%1 Year Performance102.05%-11.20%20.72%22.48% Arcadia Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RKDAArcadia Biosciences1.492 of 5 stars$5.90-4.8%$6.00+1.7%+102.0%$8.05M$5.48M-1.3860Analyst ForecastGap DownSEEDOrigin AgritechN/A$2.52flatN/A+15.0%$15.98M$13M0.0063News CoverageGap DownNCRANocera0.2658 of 5 stars$1.00flatN/A-32.3%$14.02M$23.92M0.0010Gap UpSANWS&W Seed2.8557 of 5 stars$5.28-2.0%$35.00+562.9%-30.5%$12.04M$60.44M0.00180Gap DownHigh Trading VolumeIVPInspire Veterinary Partners0.7744 of 5 stars$0.21-2.7%N/AN/A$6.19M$16.67M0.00156Positive NewsGap UpCEADCEA Industries1.7354 of 5 stars$7.51-1.8%N/A+38.6%$5.93M$6.91M0.0030Positive NewsGap DownSISIShineco0.7586 of 5 stars$2.64+4.3%N/A-90.3%$4.57M$9.80M0.0070Positive NewsEDBLEdible Garden0.4157 of 5 stars$0.17flatN/A-98.8%$3.20M$14.05M0.0050YTENYield10 BioscienceN/A$0.35-31.4%N/A-93.6%$256,000.00$60,000.000.0030Gap UpAAGRAfrican AgricultureN/A$0.01+3,900.0%N/A-100.0%$76,000.00$1.82M0.004Gap UpAAGRWAfrican AgricultureN/AN/AN/AN/A$0.00$1.75M0.0085 Related Companies and Tools Related Companies SEED Competitors NCRA Competitors SANW Competitors IVP Competitors CEAD Competitors SISI Competitors EDBL Competitors YTEN Competitors AAGR Competitors AAGRW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RKDA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
